Escolar Documentos
Profissional Documentos
Cultura Documentos
Forward-Looking Statements
This presentation may contain forward-looking statements based on current
assumptions and forecasts made by Bayer Group or subgroup management.
Various known and unknown risks, uncertainties and other factors could lead to
material differences between the actual future results, financial situation,
development or performance of the company and the estimates given here.
These factors include those discussed in Bayers public reports which are
available on the Bayer website at www.bayer.com.
The company assumes no liability whatsoever to update these forward-looking
statements or to conform them to future events or developments.
Disclaimer
Although the financial year 2014-2015 ended on March 31, 2015, Bayer
CropScience Limited neither has published any results or figures for the
mentioned period nor for the last quarter starting January 1, 2015 and ending on
March 31, 2015 of this financial year. Having said that, please understand that
we will not comment on the results of the respective periods.
In addition to that, Bayer CropScience Limited in this presentation shall be
referred to as BCSL for the sake of simplification.
Agenda
Our Mission
Bayer: Science For A Better Life
118,900 employees
Full year sales: 42.2 billion
302 subsidiaries
R&D expenditures: 3.6 billion
As of December 31, 2014
Bayer HealthCare
Business Areas
Pharmaceuticals
Consumer Care
Medical Care
Animal Health
General Medicine
Specialty Medicine
Non-prescription
Diabetes Care
Radiology
Farm animal
drugs
Vitamins and
nutritional
supplements
Rx Dermatology
products
Companion
animal products
Bayer CropScience
Business Areas
Crop Protection
Seeds
Environmental Science
Insecticides
Vegetables seeds
Professional Products
Fungicides
Consumer Products
Herbicides
SeedGrowth
Traits
Bayer MaterialScience
Business Areas
Polyurethanes
Polycarbonates
Coatings, Adhesives,
Specialties
Polycarbonate is a
Automobile components
Lighting systems
Electrical/electronic hardware
FY 2014
Strong Business Momentum Continued
CropScience
HealthCare
Pharma,
Consumer Health
22%
47%
Seeds,
Crop Protection
Sales
42.2 billion
28%
3%
Others
MaterialScience
Polyurethanes,
Polycarbonate
FY 2015
R&D and CapEx Budgets
HealthCare &
CropScience
25%
25%
Polymers &
75%
75%
Chemicals
10%
90%
90%
70%
70%
Pharma &
Crop Protection
Pharma &
Crop Protection
Materials
30%
30%
Life
Sciences
Medicine /
Biologics
Material
Sciences
Chemicals
Chemical
Industry
1900
1925
1950
1975
2000
Present day
portfolio
customer proximity
Building on core
competencies
CropScience
Legal entities in India
Bayer Bioscience Pvt. Ltd.
Agenda
Domestic
Export
12%
53%
9%
2,823
1,721
68
Other
Income
11%
85
16%
32,196
27,669
2013-14
As % to Total 2011-12
2014-15
PY
Revenue 2010-11
2013-14
2014-15
80
83
Domestic Sales
15
12
Exports
Other Operating
2
Income
2
3
Other Income
CY
Gross
Profit
Other Operating
& Other Income
17%
1%
7%
1,465
17
113
Employee
Expenses
Other
Expenses
7%
281
Depreciation &
Finance Cost
61%
38%
343
5,092
3,695
9 months
2014-15
9 months
2013-14
(16.6% to Net
Sales)
(14.1% to Net
Sales)
% to Net
Sales
PY
2014-15
2013-14
Gross33
Profit
33
Other 5
Operating Employees
6 Cost Other Expenses
15
& Other Income
(CY 6% / PY
(CY 11% / PY
6
6
16
7%)
8%)
Dep. & 1
Fin.Chrg
(CY 1% / PY
2
2%)
CY
Fixed Assets
3,197, -23%
Fixed Assets
4,177
Cash & Bank Balance
4,665, 44%
Shareholders Funds
20,648, 20%
Shareholders Funds
17,196
6%
9%
9%
7%
Trade Receivables
7,216, 20%
37%
38%
13%
13%
27,248
23,189
10%
5%
7%
Trade Payables
2,925, 21%
Other Liabilities &
Provisions
3,675, 3%
Trade
Receivables
6,007
12%
10%
Inventory
5,484, 16%
5%
8%
Inventory
4,722
11%
Trade Payables
2,411
Others
6,686, 33%
Other Liabilities
& Provisions
3,582
Others
5,037
Surplus Cash
Real estate divestments in the past
few years generated substantial
cash flows which have been
distributed partly to the shareholders
BCSL concludes all transactions at Arms Length Price which has been
verified by independent audit services. The same has also been approved by
the Board of Directors
Agenda
Q1
Q2 Q3
Challenges
Core Crops
Growth in 2014 *
Rice
+22%
Vegetables
+20%
Cotton
+15%
Fruits
+31%
Pulses
6%
Above Market
In line with Market
Below market
* Annual calendar year growth rate over 2013
Page 27 Bayer CropScience Ltd. Investor Presentation April 2015
Core Crops+
Growth in 2014*
Rice
+8%
Millet
+4%
Cotton
+30%
Mustard
+1%
Above market
In line with market
Below market
* Annual calendar year growth rate over 2013
+ Hybrid Seeds Business
Page 28 Bayer CropScience Ltd. Investor Presentation April 2015
Weed, pest
& disease
control
Resistance
Extension field
service
Optimizing yield
and quality
(Labhsutra)
Bayer Solutions
+ Advisory
Rice
Cotton
Millet
Mustard
Vegetables 1)
Benefits
Across the
food value
chain
Integrated
management
GROWER
Good Agricul-
DEMAND
tural Practices
(GAP)
Higher yield
Higher quality
Convenience
Market Access
Risk Management
Sustainable
intensification
of agriculture
1)
Insecticides
Fungicides
Herbicides - PGR
SeedGrowth products
Fungicides
Insecticides
SeedGrowth
products
Contribution to
Food Security
2015
2016-20
Seed Growth
Herbicides
17%
2020
4%
~30%
2012
~20%
58%
21%
Fungicides
Insecticides
~40%
~10%
Portfolio Shift with reference to the
Indian Market from 2012 to 2020
Biologics portfolio to be developed by 2020
Page 30 Bayer CropScience Ltd. Investor Presentation April 2015
2014
30%
25%
Incremental Yield
Incremental Profit
27%
25%
24%
20%
20%
2015
20%
17%
15%
15%
12%
12%
10%
10%
8%
10%
5%
0%
Rice
Cotton
Apple
Tomato
Red Chilli
Potato
Locations - 5
Agents - 20
Regions Covered - 15
2015
2015
2014
9.4
8.4
10.5
12
10
6000
5000
7000
4000
3000
1000
1500
2000
150
2013
2014
Acres
2015 P
Yield Q/Ac
2015
2014
Q4 2014/15 is not supportive & stretches farmers/input value chain cash flow
2015/16 will see a carry forward impact, but may be boosted by good monsoon
Global commodity prices unlikely to see fast recovery
Summary
Apr Dec 2014 weak monsoon and challenging commodity price
development impacted overall growth in Seeds and Crop Protection business
Bayer CropScience grew above market because of strong brands, ability to
offer integrated solutions, and efficient connect with farming community
Bayer CropScience's strong portfolio pipeline in line with growing segments
Bayer CropScience invests and collaborates to develop future farming
practices, solutions and technologies
Jan Mar 2015 most likely to impact industry growth for financial 2014/15
Support from Bayer CropSciences global Product Supply and R&D
functions enables BCSL to carry out its business successfully
Thank you!